Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: DexCom, Inc.

Market Cap 29.08B 500B 25.12B 23.15B 21.67B 40.61B 2,764B 41.23B 273B 107B 1,346B 109B 107B 4,659B P/E Ratio 2026 *
30.8x
P/E Ratio 2027 * 25.8x
Enterprise Value 28.71B 494B 24.8B 22.85B 21.39B 40.09B 2,729B 40.71B 270B 105B 1,328B 108B 105B 4,600B EV / Sales 2026 *
5.5x
EV / Sales 2027 * 4.77x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 month+2.65%
3 months-3.29%
6 months-1.14%
Current year+2.37%
1 month 1,064.65
Extreme 1064.65
1,241.72
Current year 1,064.65
Extreme 1064.65
1,320
1 year 1,062.55
Extreme 1062.55
1,581
3 years 1,062.55
Extreme 1062.55
2,318.97
5 years 1,062.55
Extreme 1062.55
3,366.38
10 years 212.78
Extreme 212.775
3,366.38
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 29.04B
-1.64%-3.17%-35.38%-13.04% 156B
-0.16%-1.80%-9.37%-4.84% 103B
+0.07%+2.41%-4.53%+57.08% 54.77B
+3.00%+0.30%+55.27%+51.53% 53.52B
-0.75%-3.25%-16.18%-41.67% 40.6B
-1.40%+8.93% - - 31.4B
-0.46%+4.55%+46.20%-7.99% 23.34B
-2.85%-3.53%-16.97%-1.50% 20.81B
+0.16%-2.26%-14.38%-0.16% 20.23B
Average -0.24%+0.36%+0.58%+4.93% 55.99B
Weighted average by Cap. +0.02%-0.84%-8.47%+3.04%

Financials

2026 *2027 *
Net sales 5.22B 89.86B 4.51B 4.16B 3.89B 7.29B 497B 7.41B 49.1B 19.14B 242B 19.61B 19.19B 837B 5.83B 100B 5.04B 4.64B 4.34B 8.14B 554B 8.27B 54.79B 21.36B 270B 21.88B 21.41B 934B
Net income 963M 16.55B 831M 766M 717M 1.34B 91.49B 1.36B 9.05B 3.53B 44.53B 3.61B 3.54B 154B 1.16B 19.91B 1B 921M 863M 1.62B 110B 1.64B 10.88B 4.24B 53.56B 4.34B 4.25B 185B
Net Debt -370M -6.36B -319M -294M -275M -516M -35.12B -524M -3.47B -1.35B -17.1B -1.39B -1.36B -59.19B -1.25B -21.46B -1.08B -993M -929M -1.74B -119B -1.77B -11.72B -4.57B -57.72B -4.68B -4.58B -200B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
75.37USD
Average target price
84.67USD
Spread / Average Target
+12.33%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!